These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 22433804)

  • 41. Success of repeat detrusor injections of botulinum a toxin in patients with severe neurogenic detrusor overactivity and incontinence.
    Grosse J; Kramer G; Stöhrer M
    Eur Urol; 2005 May; 47(5):653-9. PubMed ID: 15826758
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Benefits and risks of pharmacological treatments for essential tremor.
    Lyons KE; Pahwa R; Comella CL; Eisa MS; Elble RJ; Fahn S; Jankovic J; Juncos JL; Koller WC; Ondo WG; Sethi KD; Stern MB; Tanner CM; Tintner R; Watts RL
    Drug Saf; 2003; 26(7):461-81. PubMed ID: 12735785
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Botulinum toxin for essential tremor of the voice with multiple anatomical sites of tremor: a crossover design study of unilateral versus bilateral injection.
    Warrick P; Dromey C; Irish JC; Durkin L; Pakiam A; Lang A
    Laryngoscope; 2000 Aug; 110(8):1366-74. PubMed ID: 10942143
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison Between Dysport and Prosigne in the Treatment of Cervical Dystonia.
    Barbosa PM; Rodrigues GR; de Oliveira DS; de Souza CP; Tumas V
    Clin Neuropharmacol; 2015; 38(6):221-6. PubMed ID: 26536017
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Half-mirror biofeedback exercise in combination with three botulinum toxin A injections for long-lasting treatment of facial sequelae after facial paralysis.
    Lee JM; Choi KH; Lim BW; Kim MW; Kim J
    J Plast Reconstr Aesthet Surg; 2015 Jan; 68(1):71-8. PubMed ID: 25444667
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Quality of life in hemifacial spasm patient after treatment with botulinum toxin A; a 24-week, double-blind, randomized, cross-over comparison of Dysport and Neuronox study.
    Kongsengdao S; Kritalukkul S
    J Med Assoc Thai; 2012 Mar; 95 Suppl 3():S48-54. PubMed ID: 22619887
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pericranial injection of botulinum toxin type A (Dysport) for tension-type headache - a multicentre, double-blind, randomized, placebo-controlled study.
    Straube A; Empl M; Ceballos-Baumann A; Tölle T; Stefenelli U; Pfaffenrath V;
    Eur J Neurol; 2008 Mar; 15(3):205-13. PubMed ID: 18290842
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Efficacy and safety of 3- and 5-injection patterns (30 and 50 U) of botulinum toxin A (Dysport) for the treatment of wrinkles in the glabella and the central forehead region.
    Rzany B; Ascher B; Fratila A; Monheit GD; Talarico S; Sterry W
    Arch Dermatol; 2006 Mar; 142(3):320-6. PubMed ID: 16549707
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Benefits and risks of pharmacological and surgical treatments for essential tremor: disease mechanisms and current management.
    Rincon F; Louis ED
    Expert Opin Drug Saf; 2005 Sep; 4(5):899-913. PubMed ID: 16111452
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Can botulinum toxin type A injection technique influence the clinical outcome of patients with post-stroke upper limb spasticity? A randomized controlled trial comparing manual needle placement and ultrasound-guided injection techniques.
    Santamato A; Micello MF; Panza F; Fortunato F; Baricich A; Cisari C; Pilotto A; Logroscino G; Fiore P; Ranieri M
    J Neurol Sci; 2014 Dec; 347(1-2):39-43. PubMed ID: 25263601
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Botulinum toxin type a injection for lateral canthal rhytids : effect on tear film stability and tear production.
    Ho MC; Hsu WC; Hsieh YT
    JAMA Ophthalmol; 2014 Mar; 132(3):332-7. PubMed ID: 24385079
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Botulinum toxin A--injection for cervical dystonia.
    Bhaumik S; Behari M
    J Assoc Physicians India; 1999 Mar; 47(3):267-70. PubMed ID: 10999117
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Treatment of focal dystonia with botulinum toxin A].
    Sojer M; Wissel J; Müller J; Poewe W
    Wien Klin Wochenschr; 2001; 113 Suppl 4():6-10. PubMed ID: 15506045
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Botulinum toxin A may be efficacious as treatment for jaw tremor in Parkinson's disease.
    Schneider SA; Edwards MJ; Cordivari C; Macleod WN; Bhatia KP
    Mov Disord; 2006 Oct; 21(10):1722-4. PubMed ID: 16817198
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacology of botulinum toxin: differences between type A preparations.
    Rosales RL; Bigalke H; Dressler D
    Eur J Neurol; 2006 Feb; 13 Suppl 1():2-10. PubMed ID: 16417591
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A clinical test for the alcohol sensitivity of essential tremor.
    Knudsen K; Lorenz D; Deuschl G
    Mov Disord; 2011 Oct; 26(12):2291-5. PubMed ID: 22021159
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Botulinum toxin therapy for focal dystonia].
    Hahn K; Niklai E; Garzuly F; Szupera Z
    Orv Hetil; 2009 Jul; 150(29):1381-4. PubMed ID: 19581172
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Botulinum injection for the management of myofascial pain in the masticatory muscles. A prospective outcome study.
    Sidebottom AJ; Patel AA; Amin J
    Br J Oral Maxillofac Surg; 2013 Apr; 51(3):199-205. PubMed ID: 22871559
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A randomized, double-blind, placebo-controlled study to evaluate botulinum toxin type A in essential hand tremor.
    Jankovic J; Schwartz K; Clemence W; Aswad A; Mordaunt J
    Mov Disord; 1996 May; 11(3):250-6. PubMed ID: 8723140
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Levetiracetam is not effective for essential tremor.
    Elble RJ; Lyons KE; Pahwa R
    Clin Neuropharmacol; 2007; 30(6):350-6. PubMed ID: 18090460
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.